SynthesisFrontiers in pharmacology2026

Renin-angiotensin system inhibitor use and survival outcomes in lung cancer: a systematic review and meta-analysis.

Yongqian Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.